Hypokalemia and thrombocytosis could occur upon conversion of severe megaloblastic to normal erythropoiesis with vitamin B12 therapy
Consistently, meta-analysis of GWAS studies from Common Metabolic Diseases Knowledge Portal 18 shows that rs1997243-G allele is linked to increased plasma levels of LDL-C, CRP, GGT, ALP, AST, and alanine aminotransferase (ALT) in humans (Supplementary Fig

This is about designing for global scalability, compliance, and biologics maturity." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma Strategic Implementation Framework Successfully capitalizing on the GLP-1 opportunity requires comprehensive strategic pillars: Early-stage DMFs: Developing Drug Master Files for GLP-1 analogues ahead of patent expiry CDMO Infrastructure: GLP-1 focused Contract Development and Manufacturing Organization investments for regulated markets Regulatory Collaboration: Establishing collaborative pathways with global regulatory authorities Advanced Manufacturing Platforms: Sophisticated peptide synthesis capabilities AI-Integrated Quality Systems: Advanced Quality Control and Quality Assurance processes for biologics India's Competitive Positioning in Biologics India currently contributes over 20% of global generic medicines , with established expertise in chemistry-led drug development

We have reduced our fullyear outlook due to lowerthanplanned branded GLP1 penetration, which is impacted by the rapid expansion of compounding in the U.S. Former Novo CEO Lars Jrgensen, May 2025 The FDA ended the semaglutide shortage exemption soon after